BMRA biomerica.com: Earnings growth forecast for next year

Corporate company logo of Biomerica (BMRA)

Biomerica, Inc. (BMRA) develops proprietary InFocus systems for diagnosing gastrointestinal issues, ensuring protection against replication. The integration of InFoods tests into IBS treatment positions the company as a key link in personalized nutrition. Results are driven by the sales of clinical systems, where margins remain stable. Reviewing the projected net income per share growth rate on GURU.Markets, we see that 0.00 reflects the latest value of the metric.

BMRA: Biomerica, Inc Consensus forecast of earnings per share growth for next year 07/04/2022 - 11/17/2026

Analytical breakdowns for Biomerica, Inc.

- price and consensus price forecast:
Fundamental company analysis:BMRA, Biomerica, Inc.
Core merchandise of biomerica.com

This indicator measures the expected earnings per share dynamics, reflecting the business model's sensitivity to macroeconomic shifts and technological updates via the consensus forecast for forward-looking EPS growth rates. The current value of 0.00 confirms the resilience of Biomerica, Inc., as demand for personalized food intolerance diagnostics remains stable regardless of economic cycle phases, ensuring the asset's reliability.

Competitor analysis for Biomerica, Inc.

A (agilent.com) - Earnings growth forecast for next year|DGX - Net earnings per one share growth forecast for next year|Earnings growth forecast for next year ILMN|EXAS - Expected net earnings per share growth next year|Earnings growth forecast for next year RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Expected net earnings per share growth next year|Anbio Biotechnology - Earnings growth forecast for next year|Expected net earnings per share growth next year soterahealth.com|QDEL: Earnings growth forecast for next year|OPKO Health - Expected earnings per share trend next year|CDNA (CareDx, Inc) - Earnings growth forecast for next year|Net earnings per share growth forecast for next year MRVI|Net earnings per share growth forecast for next year Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Expected earnings per share trend next year|Earnings growth forecast for next year CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Expected net earnings per share growth next year|XGN - Net earnings per share growth forecast for next year|MDxHealth Inc. - Projected earnings per share increase next year|LUCD: Earnings growth forecast for next year|Prenetics Global Limited - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Insight Molecular Diagnostics, Inc.|trinitybiotech.com (TRIB) - Consensus forecast of earnings per share growth for next year|Earnings growth forecast for next year PRPH|Earnings growth forecast for next year Ainos Corp (AIMD)|Earnings growth forecast for next year CODX (codiagnostics.com)|Heart Test Laboratories - Net earnings per share growth forecast for next year|CDIO - Net earnings per share growth forecast for next year|Onconetix Corp (ONCO) - Expected earnings per share growth for next year|VRAX (Virax Biolabs Group Ltd) - Expected earnings per share growth for next year|Expected net earnings per share growth next year Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Earnings growth forecast for next year|AXDX - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year centogene.com (CNTG)|Consensus forecast of earnings per share growth for next year Enzo Biochem|Consensus forecast of earnings per share growth for next year FRES|Net earnings per one share growth forecast for next year GTG Labs|23andMe Holding Co - Earnings growth forecast for next year|PMD - Earnings growth forecast for next year